Dirnhofer, Stefan

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 20.

Journal Article

Chamuleau, Martine E D; Stenner, Frank; Chitu, Dana A; Novak, Urban; Minnema, Monique C; Geerts, Paul; Stevens, Wendy B C; Zenz, Thorsten; van Imhoff, Gustaaf W; Wu, Ka Lung; Demandt, Astrid M P; Kersten, Marie Jose; Terpstra, Wim E; Tick, Lidwine W; Deeren, Dries; Van Den Neste, Eric; Gregor, Michael; Veelken, Hendrik; Böhmer, Lara H; Caspar, Clemens B; ... (2023). R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial. The Lancet. Haematology, 10(12), e966-e975. Elsevier 10.1016/S2352-3026(23)00279-X

Konantz, Martina; Williams, Margaret; Merkel, Tamara; Reiss, Antonia; Dirnhofer, Stefan; Meyer, Sara C; Valent, Peter; George, Tracy I; Tzankov, Alexandar; Hartmann, Karin (2023). Increased TIM-3 and GAL-9 serum levels in patients with advanced systemic mastocytosis. Journal of allergy and clinical immunology, 152(4), pp. 1019-1024. Elsevier 10.1016/j.jaci.2023.07.001

Novak, Urban; Fehr, Martin; Schär, Sämi; Dreyling, Martin; Schmidt, Christian; Derenzini, Enrico; Zander, Thilo; Hess, Georg; Mey, Ulrich; Ferrero, Simone; Mach, Nicolas; Boccomini, Carola; Böttcher, Sebastian; Voegeli, Michèle; Cairoli, Anne; Ivanova, Vanesa-Sindi; Menter, Thomas; Dirnhofer, Stefan; Scheibe, Bernhard; Gadient, Sandra; ... (2023). Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine, 64, p. 102221. Elsevier 10.1016/j.eclinm.2023.102221

Fiegl, August; Dirnhofer, Stefan; Juskevicius, Darius; Zagrapan, Branislav; Dertinger, Susanne; Bösl, Andreas; Milos, Stella; Brunner, Jürgen; Bertolini, Franz; Offner, Felix A. (2023). Testicular Rosai-Dorfman disease clonally related to CMML – Case report and literature review. Pathology, research and practice, 247, p. 154548. Elsevier 10.1016/j.prp.2023.154548

Dislich, Bastian; Hoch, Dennis; Dirnhofer, Stefan; Novak, Urban; Banz, Yara (2022). An unusual pseudolymphoma in the context of necrotizing fasciitis: A case report. Medicine, 101(51), e32457. Wolters Kluwer Health 10.1097/MD.0000000000032457

Kirsch, Mark; Stehle, Gregor T; Konantz, Martina; Passweg, Jakob; Dirnhofer, Stefan; Meyer, Sara C; Hartmann, Karin (2022). Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis. The journal of allergy and clinical immunology. In practice, 10(11), 3035-3038.e1. Elsevier 10.1016/j.jaip.2022.07.014

Janowczyk, Andrew; Baumhoer, Daniel; Dirnhofer, Stefan; Grobholz, Rainer; Kipar, Anja; de Leval, Laurence; Merkler, Doron; Michielin, Olivier; Moch, Holger; Perren, Aurel; Rottenberg, Sven; Rubbia-Brandt, Laura; Rubin, Mark A; Sempoux, Christine; Tolnay, Markus; Zlobec, Inti; Koelzer, Viktor Hendrik (2022). Towards a national strategy for digital pathology in Switzerland. Virchows Archiv, 481(4), pp. 647-652. Springer 10.1007/s00428-022-03345-0

Stathis, Anastasios; Mey, Ulrich J M; Schär, Sämi; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; ... (2022). SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances, 6(13), pp. 3911-3920. American Society of Hematology 10.1182/bloodadvances.2021006520

Genta, Sofia; Ghilardi, Guido; Cascione, Luciano; Juskevicius, Darius; Tzankov, Alexandar; Schär, Sämi; Milan, Lisa; Pirosa, Maria Cristina; Esposito, Fabiana; Ruberto, Teresa; Giovanella, Luca; Hayoz, Stefanie; Mamot, Christoph; Dirnhofer, Stefan; Zucca, Emanuele; Ceriani, Luca (2022). Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers, 14(4) MDPI AG 10.3390/cancers14041018

Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386

Condoluci, Adalgisa; Théaudin, Marie; Schwotzer, Rahel; Pazhenkottil, Aju P; Arosio, Paolo; Averaimo, Manuela; Bacher, Ulrike; Bode, Peter; Cavalli, Andrea; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Gerull, Sabine; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2021). Management of transthyretin amyloidosis. Swiss medical weekly, 151(w30053), w30053. EMH Media 10.4414/smw.2021.w30053

Brkic, Sime; Stivala, Simona; Santopolo, Alice; Szybinski, Jakub; Jungius, Sarah; Passweg, Jakob R; Tsakiris, Dimitrios; Dirnhofer, Stefan; Hutter, Gregor; Leonards, Katharina; Lischer, Heidi E L; Dettmer, Matthias S; Neel, Benjamin G; Levine, Ross L; Meyer, Sara C (2021). Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia, 35(10), pp. 2875-2884. Springer Nature 10.1038/s41375-021-01391-2

Tata, Nageswara Rao; Hansen, Nils; Stetka, Jan; Luque Paz, Damien; Kalmer, Milena; Hilfiker, Julian; Endele, Max; Ahmed, Nouraiz; Kubovcakova, Lucia; Rybarikova, Margareta; Hao-Shen, Hui; Geier, Florian; Beisel, Christian; Dirnhofer, Stefan; Schroeder, Timm; Brümmendorf, Tim H; Wolf, Dominik; Koschmieder, Steffen; Skoda, Radek C (2021). JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality. Blood, 137(16), pp. 2139-2151. American Society of Hematology 10.1182/blood.2020005563

Schwotzer, Rahel; Flammer, Andreas J; Gerull, Sabine; Pabst, Thomas; Arosio, Paolo; Averaimo, Manuela; Bacher, Vera; Bode, Peter; Cavalli, Andrea; Concoluci, Adalgisa; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan W.; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2020). Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. Swiss medical weekly, 150(w20364), w20364. EMH Media 10.4414/smw.2020.20364

Kashyap, Abhishek S; Schmittnaegel, Martina; Rigamonti, Nicolò; Pais-Ferreira, Daniela; Mueller, Philipp; Buchi, Melanie; Ooi, Chia-Huey; Kreuzaler, Matthias; Hirschmann, Petra; Guichard, Alan; Rieder, Natascha; Bill, Ruben; Herting, Frank; Kienast, Yvonne; Dirnhofer, Stefan; Klein, Christian; Hoves, Sabine; Ries, Carola H; Corse, Emily; De Palma, Michele; ... (2020). Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 117(1), pp. 541-551. National Academy of Sciences NAS 10.1073/pnas.1902145116

Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna; Østenstad, Bjørn; Mey, Ulrich J. M.; Rauch, Daniel; Wahlin, Björn E.; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés J. M.; Lohri, Andreas; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Bargetzi, Mario; Mingrone, Walter; Krasniqi, Fatime; ... (2019). Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood, 134(4), pp. 353-362. American Society of Hematology 10.1182/blood-2018-10-879643

Puddinu, Viola; Casella, Sabrina; Radice, Egle; Thelen, Sylvia; Dirnhofer, Stefan; Bertoni, Francesco; Thelen, Marcus (2017). ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration. OncoTarget, 8(49), pp. 85068-85084. Impact Journals LLC 10.18632/oncotarget.18844

Meyer, Sara C; Ghosh, Nilabh; Stivala, Simona; Baerenwaldt, Anne; Hao-Shen, Hui; Dirnhofer, Stefan; Dettmer, Matthias; Simillion, Cédric; Chiu, Sophia; Keller, Matthew; Kleppe, Maria; Hilpert, Morgane; Buser, Andreas S.; Passweg, Jakob R.; Radimersk, Thomas; Skoda, Radek C.; Levine, Ross L. (2017). Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms. Blood, 130(Suppl. 1), p. 381. American Society of Hematology

Mauermann, Nora; Burian, Julia; von Garnier, Christophe; Dirnhofer, Stefan; Germano, Davide; Schuett, Christine; Tamm, Michael; Bingisser, Roland; Eriksson, Urs; Hunziker, Lukas (2008). Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease. American journal of respiratory and critical care medicine, 178(4), pp. 379-88. New York, N.Y.: American Lung Association 10.1164/rccm.200711-1648OC

Matt, Peter; Fu, Zongming; Carrel, Thierry; Huso, David L; Dirnhofer, Stefan; Lefkovits, Ivan; Zerkowski, Hans-Reinhard; Van Eyk, Jennifer E (2007). Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. Journal of molecular and cellular cardiology, 43(6), pp. 792-801. Oxford: Elsevier 10.1016/j.yjmcc.2007.08.011

This list was generated on Fri Mar 29 16:08:06 2024 CET.
Provide Feedback